Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma
Clinical trial NCT04508647 · COMPLETED
Trial details
- NCT number
- NCT04508647
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2022-07-14
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.